Drug Trial Radar · NCT05851443
A Study to Evaluate the Efficacy and Safety Study of Povorcitinib in Participants With Inadequately Controlled Moderate to Severe Asthma
Last checked: Nov 20, 2026Latest source record: Jul 7, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
247
Actual
Start
Jul 11, 2023
Primary completion
Nov 20, 2026
Study completion Jul 5, 2027
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- May 9, 2023
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Conditions
- Moderate to Severe Asthma
Interventions
povorcitinibDrug
povorcitinib
placeboOther
placebo
ICS-LABADrug
Background Therapy
Primary outcomes
What the sponsor says the trial is designed to measure.
- Absolute change in pre-bronchodilator forced expiratory volume in the first 1 second (pre-BD FEV1)Time frame: Baseline ; Week 24
Locations
82 sites in 7 countries. Site status is shown where the registry gives one.
Allervie Clinical Research
Birmingham, Alabama
Kern Allergy Medical Clinic, Inc
Bakersfield, California
Integrated Research of Inland, Inc
Upland, California
Qway Research
Hialeah, Florida
Direct Helpers Research Center
Hialeah, Florida
Care Research Inc
Miami, Florida
Verus Clinical Research Corp
Miami, Florida
Dr. de Armas Research Center, Llc
Miami, Florida
Care Research Center, Inc
Miami, Florida
Anderson Allergy and Asthma
Orlando, Florida
Heuer Md Research Inc
Orlando, Florida
Advanced Clinical Research Atlanta
Atlanta, Georgia
Covenant Pulmonary Critical Care
East Point, Georgia
Northshore Medical Group
Glenview, Illinois
Henry Ford Hospital
Detroit, Michigan
Aa Medical Research Center
Flint, Michigan
Revive Research Institute
Southfield, Michigan
Northwell Health Physician Partners
New Hyde Park, New York
Pioneer Clinical Research Ny
New York, New York
Montefiore Medical Center (Mmc)
The Bronx, New York
Onsite Clinical Solutions, Llc Charlotte Central Office
Charlotte, North Carolina
Temple University Hospital
Philadelphia, Pennsylvania
Clinical Research of Rock Hill
Rock Hill, South Carolina
Howland Allergy and Asthma Pllc Dba Orion Clinical Research
Austin, Texas
Linq Research, Llc
Pearland, Texas
Quality Assurance Research Center
San Antonio, Texas
Fundacion Respirar
Buenos Aires, Argentina
Fundacion Cidea
Buenos Aires, Argentina
Mautalen Salud E Investigacion
Buenos Aires, Argentina
Care: Centro de Alergia Y Enfermedades Respiratorias
CABA, Argentina
INAER
Capitalfederal, Argentina
Centro de Medicina Respiratoria
Concepción del Uruguay, Argentina
Instituto de Medicina Respiratoria - Imer
Córdoba, Argentina
Fundacion Enfisema
Mar del Plata, Argentina
Centro Medico Dharma
Mendoza, Argentina
Polo de Salud Vistalba
Mendoza, Argentina
Fundacion Scherbovsky
Mendoza, Argentina
INSARES
Mendoza, Argentina
Centro Respiratorio Quilmes
Quilmes, Argentina
Centro Respiratorio Infantil
Rosario, Argentina
Showing 40 of 82 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.